Executive Summary
This digest covers two HHS contracts totaling $1.52B, with zero defense exposure, highlighting a dominant civilian agency theme. The standout signal is Emergent Product Development Gaithersburg Inc.'s $1.41B sole-source-like award from HHS, representing 93% of total value, which is a massive bullish signal for the company but carries concentration risk given its unknown competitive moat and pricing structure.
The second contract, Managed Care Advisors Inc.'s $107M CDC provider network deal, is neutral, offering stable multi-year revenue through November 2026 but with moderate competitive pressure from full-and-open competition. Key risk: Emergent's contract lacks transparency on pricing and competition, making it vulnerable to protests or budget scrutiny, while the CDC contract's time-and-materials pricing limits margin upside.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior All HHS Contracts digest from August 12, 2026.
Investment Signals (2)
- Emergent Product Development Gaithersburg Inc. Secures $1.41B HHS Contract (MEDIUM)▲
Emergent was awarded a $1.41B defense contract from HHS, the largest in this digest, signaling strong government demand for its products/services despite unknown competitive dynamics.
- Managed Care Advisors Inc. Wins $107M CDC Provider Network Contract (HIGH)▲
Managed Care Advisors secured a $107.3M definitive contract from the CDC for a nationwide provider network (WTCHP), with $106.9M already obligated, indicating near-full funding and stable execution.
Risk Flags (3)
- Concentration [CRITICAL RISK]▼
Emergent Product Development Gaithersburg Inc.'s $1.41B contract accounts for 93% of total digest value, creating extreme single-contract concentration risk for the company if funding is delayed or protested.
- Execution [MEDIUM RISK]▼
Managed Care Advisors Inc.'s contract uses time-and-materials pricing, which reduces margin risk but limits profit upside; full-and-open competition suggests potential for margin compression on future awards.
- Budget [MEDIUM RISK]▼
Both contracts are civilian HHS awards, making them vulnerable to discretionary budget cuts or Continuing Resolution delays, particularly if HHS faces sequestration or policy shifts.
Opportunities (2)
- ◆
Emergent Product Development Gaithersburg Inc.'s $1.41B award suggests HHS is prioritizing medical countermeasure development, creating follow-on opportunities for similar biodefense contractors.
- ◆
Managed Care Advisors Inc.'s $107M CDC contract runs through November 2026, with options for extension, providing a stable revenue base that could be leveraged for additional CDC or HHS contracts.
Sector Themes (2)
- ◆
Both contracts are HHS awards totaling $1.52B, with zero defense exposure, indicating strong civilian agency spending on healthcare services and products, particularly for public health preparedness.
- ◆
The digest shows a stark contrast: a single $1.41B award to Emergent (likely a large-cap) versus a $107M award to Managed Care Advisors (mid-cap), highlighting that smaller contractors face more competitive pressure.
Watch List (2)
- 👁
{"entity" => "Emergent Product Development Gaithersburg Inc.", "reason" => "The $1.41B HHS contract is massive but lacks transparency on pricing and competition, making it a key watch for protest risk or budget scrutiny.", "trigger" => "Protest filing or HHS budget hearing on medical countermeasure contracts"}
- 👁
{"entity" => "Managed Care Advisors, Inc.", "reason" => "The $107M CDC contract has near-full funding obligated, but the time-and-materials pricing and full competition signal potential margin pressure.", "trigger" => "CDC budget allocation for health insurance carrier services or competitor wins"}
Get daily alerts with 2 investment signals, 3 risk alerts, 2 opportunities and full AI analysis of all 2 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: All HHS Contracts
🇺🇸 More from United States
View all →August 13, 2026
US Pre-Market SEC Filings Roundup — August 13, 2026
US Pre-Market SEC Filings Roundup
August 13, 2026
USA Corporate Events Calendar — August 13, 2026
USA Corporate Events Calendar
August 13, 2026
USA Earnings Calls Schedule — August 13, 2026
USA Earnings Calls Schedule
August 13, 2026
Contract Option Exercises — August 13, 2026
Contract Option Exercises